A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck. Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Chaudhry MA, Wahl R, Forastiere A, Gillison M (2012) Clin Cancer Res 18: 1735-42 Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy. Smith CA, Mont S, Traver G, Sekhar KR, Crooks PA, Freeman ML (2016) Oncotarget 7: 77926-77936 Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Donnelly EF, Geng L, Wojcicki WE, Fleischer AC, Hallahan DE (2001) Radiology 219: 166-70 A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients. Willey CD, Murphy BA, Netterville JL, Burkey BB, Shyr Y, Shakhtour B, Kish B, Raben D, Chen C, Song JI, Kane MA, Cmelak AJ (2007) Int J Radiat Oncol Biol Phys 67: 1323-31 A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). Choy H, Devore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH (2000) Int J Radiat Oncol Biol Phys 47: 931-7 Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ (2010) Int J Radiat Oncol Biol Phys 77: 468-76 In Reply to Sahadevan. Dilmanian FA, Eley JG, Krishnan S (2015) Int J Radiat Oncol Biol Phys 93: 1164-5 Minibeam therapy with protons and light ions: physical feasibility and potential to reduce radiation side effects and to facilitate hypofractionation. Dilmanian FA, Eley JG, Krishnan S (2015) Int J Radiat Oncol Biol Phys 92: 469-74 Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, Clark I, Weiss G, Sosman J, II Smith W, Dutcher P, Gollob J, Longmate J, Johnson D (2002) J Cancer Res Clin Oncol 128: 214-8 Risk-optimized proton therapy to minimize radiogenic second cancers. Rechner LA, Eley JG, Howell RM, Zhang R, Mirkovic D, Newhauser WD (2015) Phys Med Biol 60: 3999-4013 The effect of free-electron laser pulse structure on mid-infrared soft-tissue ablation: biological effects. Mackanos MA, Kozub JA, Hachey DL, Joos KM, Ellis DL, Jansen ED (2005) Phys Med Biol 50: 1885-99 Proton minibeams-a springboard for physics, biology and clinical creativity. Dilmanian FA, Venkatesulu BP, Sahoo N, Wu X, Nassimi JR, Herchko S, Lu J, Dwarakanath BS, Eley JG, Krishnan S (2020) Br J Radiol 93: 20190332 Spatially fractionated proton minibeams. Meyer J, Eley J, Schmid TE, Combs SE, Dendale R, Prezado Y (2019) Br J Radiol 92: 20180466
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.